Tramadol: Does it have a role in emergency medicine?

EMA - Emergency Medicine Australasia

Volumn 17, Issue 1, 2005, Pages 73-83

  Close, Benjamin R ^a  

^a TOWNSVILLE HOSPITAL   (Australia)

Author keywords

Emergency medicine; Pain; Tramadol

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; ANOREXIGENIC AGENT; ANTIDEPRESSANT AGENT; BUSPIRONE; CARBAMAZEPINE; CENTRAL DEPRESSANT AGENT; CIMETIDINE; COCAINE; CODEINE; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DEXTROMETHORPHAN; ERYTHROMYCIN; FLECAINIDE; HYPERICUM PERFORATUM EXTRACT; KETOCONAZOLE; LITHIUM; LYSERGIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; ONDANSETRON; PENTAZOCINE; PETHIDINE; QUINIDINE; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; WARFARIN;

ABDOMINAL PAIN; AGITATION; ANALGESIA; ANALGESIC ACTIVITY; ARTHRITIS; ATAXIA; BACKACHE; BONE PAIN; CHRONIC PAIN; COMA; CONFUSION; CONSTIPATION; CONVULSION; DIAPHORESIS; DIARRHEA; DIZZINESS; DROWSINESS; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; EMERGENCY HEALTH SERVICE; FEVER; FIRST PASS EFFECT; HALLUCINATION; HEADACHE; HUMAN; HYPERREFLEXIA; HYPOMANIA; LETHARGY; LIVER DISEASE; MOTOR DYSFUNCTION; MYALGIA; MYOCLONUS; NAUSEA; NEUROPATHIC PAIN; PAIN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SEIZURE THRESHOLD; SEROTONIN SYNDROME; SHIVERING; SWEATING; SYSTEMATIC REVIEW; THORAX PAIN; TOOTH PAIN; TREMOR; URINE RETENTION; VOMITING; XEROSTOMIA;

EID: 13544270927     PISSN: 17426731     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-6723.2005.00671.x     Document Type: Review

References (69)

1. Caswell A (Managing Ed.) Tramal full prescribing information. MMS Online. Sydney: MMS Australia, 2004. Available from URL: http://ckn.health.qld.gov.au
2. Raffa RB, Friderichs E, Reiman W et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an atypical opioid analgesic. J. Pharmacol. Exp. Ther. 1992; 260: 275-85.
3. Bamigbade TA, Langford RM. The clinical use of tramadol hydrochloride. Pain Rev. 1998; 5: 155-82.
4. Desmeules JA. The tramadol option. Eur. J. Pain 2000; 4 (Suppl. A): 15-21.
5. Eggers KA, Power I. Tramadol. Br. J. Anaesth. 1995; 74: 247-9.
6. Cossman M, Kohnen C. General tolerability and adverse event profile of tramadol hydrochloride. Rev. Contemp. Pharmacother. 1995; 6: 513-31.
7. Katz WA. Use of nonopioid analgesics and adjunctive agents in the management of pain in rheumatic diseases. Curr. Opin. Rheumatol. 2002; 14: 63-71.
8. Buccellati C, Sala A, Ballerio R et al. Tramadol anti-inflammatory activity is not related to a direct inhibitory action on prostaglandin endoperoxides synthase [Abstract]. Eur. J. Pain 2000; 4: 413-15.
9. Raffa RB, Nayak RK, Minn FL. The mechanism(s) of action and pharmacokinetics of tramadol hydrochloride. Rev. Contemp. Pharmacother. 1995; 6: 485-97.
10. Sorge J, Stadier T. Comparison of the analgesic efficacy and tolerability of tramadol 100 mg sustained-release tablets and 50 mg capsules for the treatment of chronic low back pain. Clin. Drug. Invest. 1997; 14: 157-64.
11. Rose JB, Finkel JC, Arquedas-Mohs A, Himelstein BP, Schreiner M, Medve RA. Oral tramadol for the treatment of pain of 7-30 days' duration in children. Anesth. Analg. 2003; 96: 78-81.
12. Kaye K, Theaker N. Tramadol - a position statement of the NSW therapeutic assessment group. Available from URL: http:/http://www.nswtag.org.au [Accessed September 2001].
13. Hoogewijs J, Diltoer MW, Hubloue I et al. A prospective, open, single blind, randomized study comparing four analgesics in the treatment of peripheral injury in the emergency department. Eur. J. Emerg. Med. 2000; 7: 119-23.
14. Turturro MA, Paris PM, Larkin GL. Tramadol versus hydrocodone- acetaminophen in acute musculoskeletal pain: a randomized, double-blind clinical trial. Ann. Emerg. Med. 1998; 32: 139-43.
15. Vergnion M, Degesves S, Garcet L, Magotteaux V. Tramadol, an alternative to morphine for treating posttraumatic pain in the prehospital situation. Anesth. Analg. 2001; 92: 1543-6.
16. Lehmann KA. Tramadol for the management of acute pain. Drugs 1994; 47 (Suppl. 1): 19-32.
17. Bijlsma JWJ. Analgesia and the patient with osteoarthritis. Am. J. Ther. 2002; 9: 189-97.
18. Roth SH. Efficacy and safety of tramadol HCl in breakthrough musculoskeletal pain attributed to osteoarthritis. J. Rheumatol. 1998; 25: 1358-63.
19. Silverfield JC, Kamin M, Wu SC et al. Tramadol/acetaminophen combination tablets for the treatment of osteoarthritis flare pain: a multicenter, outpatient, randomized, double-blind, placebo-controlled parallel-group, add-on study. Clin. Ther. 2002; 24: 282-97.
20. Schnitzer TJ, Kamin M, Olson WH. Tramadol allows reduction of naproxen dose among patients with naproxen responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study. Arthritis Rheum. 1999; 42: 1370-7.
21. McClellan K, Scott LJ. Adis drug profile: tramadol/paracetamol. Drugs 2003; 63: 1079-86.
22. Katz WA. Pharmacology and clinical experience with tramadol in osteoarthritis. Drugs 1996; 52 (Suppl. 3): 39-47.
23. Mullican WS, Lacy JR. Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comparative trial. Clin. Ther. 2001; 23: 1429-45.
24. Muller FO, Odendaal CL, Muller FR et al. Comparison of the efficacy and tolerability of a paracetamol/codeine fixed dose combination with tramadol in patients with refractory chronic back pain. Arzneimittelforschung (Drug Research) 1998; 48: 675-9.
25. Schnitzer TJ, Gray WL, Zorba Paster R, Kamin M. Efficacy of tramadol in treatment of chronic low back pain. J. Rheumatol. 2000; 27: 772-8.
26. Sindrup SH, Andersen G, Madsen C, Smith T, Brosen K, Jensen TS. Tramadol relieves pain and allodynia in polyneuropathy: a randomized, double-blind, controlled trial. Pain 1999; 83: 85-90.
27. Harati Y, Gooch C, Swenson M et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998; 50: 1842-6.
28. Harati Y, Gooch C, Swenson M et al. Maintenance of the long term effectiveness of tramadol in treatment of the pain of diabetic neuropathy [Abstract]. j. Diabetes Complications 2000; 14: 65-70.
29. Gobel H, Stadler TH. Treatment of pain due to postherpetic neuralgia with tramadol. Results of an open, parallel pilot study vs clomipramine with or without levomepromazine. Clin. Drug. Invest. 1995; 10: 208-14.
30. Robbins L. Tramadol for tension-type headache [Letter]. Headache 2004; 44: 192-3.
31. Mehlish DR, Minn F, Brown P. Tramadol hydrochloride: efficacy compared to codeine sulfate, acetaminophen with dextropropoxyphene and placebo in dental extraction pain [Abstract]. Clin. Pharmacol. Ther. 1990; 47: 187.
32. Moore PA. Pain management in dental practice: tramadol versus codeine combinations. J. Am. Dent. Assoc. 1999; 130: 1075-9.
33. Moore RA, McQuay HJ. Single patient data meta-analysis of 3453 postoperative patients: oral tramadol versus placebo, codeine and combination analgesics. Pain 1997; 69: 287-94.
34. Eray O, Cete Y, Oktay C et al. Intravenous single dose tramadol versus meperidine for pain relief in renal colic. Eur. J. Anaesthesiol. 2002; 19: 368-70.
35. Nicolas Torralba JA, Rigabert Montiel M, Banon Perez V, Valdelvira Nadel P, Ferez Albacete M. Intramuscular ketorolac compared with subcutaneous tramadol in the initial emergency treatment of renal colic [Abstract]. Arch. Esp. Urol. 1999; 52: 435-7.
36. Stankov G, Schmieder G, Zerle G, Schinzel S, Brune K. Double blind study with dipyrone versus tramadol and butylscopolamine in acute renal colic pain. World J. Urol. 1994; 12: 155-61.
37. Wilder-Smith CH, Hill L, Osier W, O'Keefe S. Effect of tramadol and morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis. Dig. Dis. Sci. 1999; 44: 1107-16.
38. Schmieder G, Stankov G, Zerle G, Schinzel S, Brune K. Observer blind multicentre study with dipyrone versus tramadol and butylscopolamine in acute biliary colic pain. Drug Res. 1993; 43: 1216-21.
39. Radbruch L, Grond S, Lehmann KA. A risk-benefit assessment of tramadol in the management of pain. Drug Saf. 1996; 15:8-29.
40. Shipton EA. Tramadol - Present and future. Anaesth. Intensive Care 2000; 28: 363-74.
41. Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs 2000; 60: 139-76.
42. Stankow S. Haemodynamic effects of tramadol and morphine in patients with acute myocardial infarction [Abstract]. Proceedings of the 7th World Congress on Pain; August 1993, Paris, France. Seattle: International Association for the Study of Pain Press, 1995; 293.
43. Rauck RL, Ruoff GE, McMillen JI. Comparison of tramadol and acetaminophen with codeine for long term pain management in elderly patients. Curr. Ther. Res. 1994; 55: 1417-31.
44. Gibson TP. Pharamcokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl. Am. J. Med. 1996; 101 (Suppl. 1A): 47S-53S.
45. Rhoda Lee C, McTavish D, Sorkin EM. Tramadol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs 1993; 46: 313-40.
46. AUSTRALIAN ADVERSE DRUG REACTIONS ADVISORY COMMITTEE. Tramadol - four years' experience. Aust. Adv. Drug React. Bull. 2003; 22: 2.
47. Gasse C, Derby L, Vasilakis-Scaramozza C, Jick H. Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy 2000; 20: 629-34.
48. Jick H, Derby LE, Vasilakis C, Fife D. The risk of seizures associated with tramadol. Pharmacotherapy 1998; 18: 607-11.
49. Gardner JS, Blough D, Drinkard CR et al. Tramadol and seizures: a surveillance study in a managed care population. Pharmacotherapy 2000; 20: 1423-31.
50. Kahn LH, Alderfer RJ, Graham DJ. Seizures reported with tramadol [Letter]. JAMA 1997; 278: 1661.
51. Knisely JS, Campbell ED, Dawson KS, Schnell SH. Tramadol post-marketing surveillance in health care professionals. Drug Alcohol Depend. 2002; 68: 15-22.
52. ANONYMOUS. Withdrawal syndrome and dependence: tramadol too. Prescr. Int. 2003; 12: 99-100.
53. Preston KL, Jasinski DR, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend. 1991; 27: 7-17.
54. Miranda HF, Pinardi G. Antinociception, tolerance, and physical dependence comparison between morphine and tramadol. Pharmacol. Bochem. Behav. 1998; 61: 357-60.
55. Yates WR, Nguyen MH, Warnock JK. Tramadol dependence with no history of substance abuse [Letter]. Am. J. Psychiatry 2001; 158: 964.
56. Senay EC, Adams EH, Geller A et al. Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend. 2003; 69: 233-41.
57. Bamingbade TA, Langford RM. Tramadol hydrochloride: an overview of current use. Hosp. Med. 1998; 59: 373-6.
58. AUSTRALIAN DRUG EVALUATION COMMITTEE. Prescribing Medicines in Pregnancy, 4th edn. Canberra: Australian Government Publishing Service, 1999.
59. Mehta DK (ed.). British National Formulary. Number 46 (September 2003). London: British Medical Association, The Pharmaceutical Press, 2003.
60. Buckley N, Dawson A, Whyte I. HyperTox 2004 v0201. Australia: MediTox, 2004.
61. AUSTRALIAN ADVERSE DRUG REACTIONS ADVISORY COMMITTEE. Tramadol and serotonin syndrome. Aust. Adv. Drug React. Bull. 2001; 20: 14.
62. Mahlberg R, Kunz D, Sasse J, Kirchheiner J. Serotonin syndrome with tramadol and citalopram [Letter]. Am. J. Psychiatry 2004; 161: 1129.
63. Kesavan S, Sobala GM. Serotonin syndrome with fluoxetine plus tramadol. J. R. Soc. Med. 1999; 92: 474-5.
64. Ripple MG, Pestaner JP, Levine BS, Smialek JE. Lethal combination of tramadol and multiple drugs affecting serotonin. Am. J. Forensic Med. Pathol. 2000; 21: 370-4.
65. Spiller HA, Gorman SE, Villalobos D et al. Prospective multicenter evaluation of tramadol exposure. J. Toxicol. Clin. Toxicol. 1997; 35: 361-4.
66. Sternbach H. The serotonin syndrome. Am. J. Psychiatry 1991; 148: 705-13.
67. Loughrey MB, Loughrey CM, Johnston S, O'Rourke D. Fatal hepatic failure following accidental tramadol overdose [Abstract]. Forensic Sci. Int. 2003; 134: 232-3.
68. TRAMAL DATA SHEET. Medsafe Information for Health Professionals. Wellington: Medsafe; New Zealand Medicines and Medical Devices Safety Authority, 2004. Available from URL: http://www.medsafe.govt.nz
69. Rossi S, Hurley E, Vitry A et al. (eds). Australian Medicines Handbook. Adelaide: Australian Medicines Handbook, 2004.